[Resveratrol and newly synthetized resveratrol analogs in therapy of prostate carcinoma].
Djavan
B
B
Klinik für Urologie, Universität, Währinger Gürtel 18-20, A-1090 Wien, Osterreich. bdjavan@hotmail.com
Marihart
S
S
Kuehhas
F
F
Rom
M
M
Partin
A
A
Schalken
J
J
Sekeres
T
T
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000627:therapeutic use*; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D000077185:Resveratrol; D016196:S Phase / Q000187:drug effects; D013267:Stilbenes / Q000009:adverse effects / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D014410:Tumor Stem Cell Assay
D000972:Antineoplastic Agents, Phytogenic; D013267:Stilbenes; D000077185:Resveratrol
J Androl. 2007 Mar-Apr;28(2):282-93
17050787
Cancer Biol Ther. 2004 Sep;3(9):889-90
15467424
Anticancer Res. 2004 Sep-Oct;24(5A):2783-840
15517885
Bioorg Med Chem. 2004 Nov 1;12(21):5571-8
15465334
Neoplasma. 2005;52(6):450-5
16284688
Exp Hematol. 2006 Oct;34(10):1377-84
16982330
Toxicol Appl Pharmacol. 2007 Nov 1;224(3):274-83
17306316
Nutr Cancer. 2000;37(2):223-33
11142097
Oncol Rep. 2006 Sep;16(3):617-24
16865264
Nat Rev Drug Discov. 2006 Jun;5(6):493-506
16732220
Drugs. 2007;67(6):821-45
17428102
Expert Opin Investig Drugs. 2006 Oct;15(10):1191-200
16989596
Clin Cancer Res. 2002 Mar;8(3):893-903
11895924
Rev Port Cardiol. 2006 Nov;25(11):1043-58
17274460
Mol Cancer Ther. 2006 May;5(5):1335-41
16731767